Avecho Biotechnology Limited (ASX:AVE)

Avecho Biotechnology Revenue

Avecho Biotechnology had revenue of 59.60K AUD in the half year ending June 30, 2026, a decrease of -80.91%. This brings the company's total for the last twelve months to 737.30K, down -46.59% year-over-year. In the year 2025, Avecho Biotechnology had annual revenue of 1.24M with 9.28% growth. That makes Avecho Biotechnology the 44,489th largest company in the world by revenue and 1,038th in Australia.

• Revenue (ttm): 737.30K
• Revenue Growth: -46.59%
• P/S Ratio: 89.09
• Revenue / Employee: 49.15K
• Employees: 15
• Market Cap: 65.68M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Switzerland 1.07M 86.3%
• Australia 136.98K 11.1%
• India 22.50K 1.8%
• France 9.75K 0.8%

Fiscal year ended Dec 31, 2025 See the full Avecho Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.24M	105.09K	9.28%
Dec 31, 2024	1.13M	659.12K	139.19%
Dec 31, 2023	473.55K	-655.71K	-58.07%
Dec 31, 2022	1.13M	335.66K	42.30%
Dec 31, 2021	793.60K	408.97K	106.33%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 20, 2026

Data Sources Report a data error